Reply to the comments on: Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials

Meta Analysis ◽

Small Cell ◽

Comment on: Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials

Lung Cancer ◽

10.1016/j.lungcan.2018.09.003 ◽

2018 ◽

Vol 126 ◽

pp. 224 ◽

Cited By ~ 1

Author(s):

Ran Xu ◽

Jing Zhu

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Potential Benefit ◽

Meta Analysis ◽

Small Cell ◽

Erlotinib in combination with bevacizumab has potential benefit in non-small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials

Lung Cancer ◽

10.1016/j.lungcan.2018.05.011 ◽

2018 ◽

Vol 122 ◽

pp. 10-21 ◽

Cited By ~ 15

Author(s):

Binghao Zhao ◽

Wenxiong Zhang ◽

Dongliang Yu ◽

Jianjun Xu ◽

Yiping Wei

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Potential Benefit ◽

Meta Analysis ◽

Small Cell ◽

Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials

ESMO Open ◽

10.1016/j.esmoop.2021.100251 ◽

2021 ◽

Vol 6 (5) ◽

pp. 100251

Author(s):

F. Conforti ◽

L. Pala ◽

E. Pagan ◽

C. Corti ◽

V. Bagnardi ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Indirect comparison between pembrolizumab and nivolumab for the treatment of non-small cell lung cancer: A meta-analysis of randomized clinical trials

International Immunopharmacology ◽

10.1016/j.intimp.2017.05.019 ◽

2017 ◽

Vol 49 ◽

pp. 85-94 ◽

Cited By ~ 9

Author(s):

Tzu-Rong Peng ◽

Fang-Pei Tsai ◽

Ta-Wei Wu

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Indirect Comparison ◽

Small Cell ◽

Gefitinib and Erlotinib in Metastatic Non‐Small Cell Lung Cancer: A Meta‐Analysis of Toxicity and Efficacy of Randomized Clinical Trials

The Oncologist ◽

10.1634/theoncologist.2014-0154 ◽

2015 ◽

Vol 20 (4) ◽

pp. 400-410 ◽

Cited By ~ 67

Author(s):

Mauricio Burotto ◽

Elisabet E. Manasanch ◽

Julia Wilkerson ◽

Tito Fojo

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Clinical Profile of Cyclooxygenase-2 Inhibitors in Treating Non-Small Cell Lung Cancer: A Meta-Analysis of Nine Randomized Clinical Trials

PLoS ONE ◽

10.1371/journal.pone.0151939 ◽

2016 ◽

Vol 11 (3) ◽

pp. e0151939 ◽

Cited By ~ 19

Author(s):

Yuan Yuan Zhou ◽

Zhi Gang Hu ◽

Fan Jun Zeng ◽

Jiao Han

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Clinical Profile ◽

Small Cell Lung ◽

Cyclooxygenase 2 Inhibitors

Anti-PD-1/anti-PD-L1 immunotherapy versus docetaxel for previously treated advanced non-small cell lung cancer: a systematic review and meta-analysis of randomised clinical trials

ESMO Open ◽

10.1136/esmoopen-2017-000236 ◽

2017 ◽

Vol 2 (3) ◽

pp. e000236 ◽

Cited By ~ 17

Author(s):

Allan Ramos-Esquivel ◽

Alicia van der Laat ◽

Raquel Rojas-Vigott ◽

Melissa Juárez ◽

Luis Corrales-Rodríguez

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Randomised Clinical Trials ◽

Small Cell Lung ◽

Previously Treated

Cisplatin in non-small cell lung cancer (NSCLC)—Reducing the most prominent toxicity, emesis: Results of a meta-analysis with 1527 patients in randomized clinical trials (RCTs) testing the addition of an NK1 antagonist

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.8064 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8064-8064 ◽

Cited By ~ 1

Author(s):

R. J. Gralla ◽

H. Raftopoulos ◽

E. Bria ◽

P. J. Hesketh

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Nk1 Antagonist

Non-conventional radiotherapy versus conventional radiotherapy for inoperable non-small-cell lung cancer: A meta-analysis of randomized clinical trials

Thoracic Cancer ◽

10.1111/j.1759-7714.2011.00094.x ◽

2012 ◽

Vol 3 (3) ◽

pp. 269-279 ◽

Cited By ~ 4

Author(s):

Qiu-Ning Zhang ◽

Dao-Ying Wang ◽

Xiao-Hu Wang ◽

Tian-jin Hui ◽

Ke-Hu Yang ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Conventional Radiotherapy

Meta-analysis of Randomized Clinical Trials Comparing Cisplatin to Carboplatin in Patients With Advanced Non-Small-Cell Lung Cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70141-6 ◽

2006 ◽

Vol 2006 ◽

pp. 199-201

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽